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Abstract
Background:  The evolution of antibiotic resistance in bacteria is a topic of major medical
importance. Evolution is the result of natural selection acting on variant phenotypes. Both the rigid
base sequence of DNA and the more plastic expression patterns of the genes present define
phenotype.
Results: We investigated the evolution of resistant E. coli when exposed to low concentrations of
antibiotic. We show that within an isogenic population there are heritable variations in gene
expression patterns, providing phenotypic diversity for antibiotic selection to act on. We studied
resistance to three different antibiotics, ampicillin, tetracycline and nalidixic acid, which act by
inhibiting cell wall synthesis, protein synthesis and DNA synthesis, respectively. In each case survival
rates were too high to be accounted for by spontaneous DNA mutation. In addition, resistance
levels could be ramped higher by successive exposures to increasing antibiotic concentrations.
Furthermore, reversion rates to antibiotic sensitivity were extremely high, generally over 50%,
consistent with an epigenetic inheritance mode of resistance. The gene expression patterns of the
antibiotic resistant E. coli were characterized with microarrays. Candidate genes, whose altered
expression might confer survival, were tested by driving constitutive overexpression and
determining antibiotic resistance. Three categories of resistance genes were identified. The
endogenous β-lactamase gene represented a cryptic gene, normally inactive, but when by chance
expressed capable of providing potent ampicillin resistance. The glutamate decarboxylase gene, in
contrast, is normally expressed, but when overexpressed has the incidental capacity to give an
increase in ampicillin resistance. And the DAM methylase gene is capable of regulating the
expression of other genes, including multidrug efflux pumps.
Conclusion: In this report we describe the evolution of antibiotic resistance in bacteria mediated
by the epigenetic inheritance of variant gene expression patterns. This provides proof in principle
that epigenetic inheritance, as well as DNA mutation, can drive evolution.
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Background
Evolution requires phenotypic variation, selection, and
heritability. It is generally assumed that mutation pro-
vides the single source of biological diversity that fuels
evolution. In this report we describe evolution without
mutation.
We investigated the evolution of antibiotic resistance by
bacteria, a topic of some importance. Bacterial and viral
infections are responsible for approximately 5–10% of
deaths in industrialized nations, over 30% of deaths in
Southeast Asia, and over 60% of deaths in Africa, accord-
ing to the Global Health Council, and antibiotic resistant
strains are becoming increasingly prevalent.
This study began as an effort to better understand the ori-
gin of satellite colonies, the small colonies that typically
surround a colony of E. coli carrying, for example, a plas-
mid conferring ampicillin (amp) resistance during a sub-
cloning experiment. It is generally stated that the colony
of cells carrying the plasmid is able to reduce the concen-
tration of amp in its vicinity, thereby allowing other cells
to survive. It is interesting to note, however, that normally
there will be a large number of cells immediately sur-
rounding the resistant colony, and only a few of these cells
form satellite colonies. What distinguishes these few cells
and allows them to grow rather than die? In this report we
show that the mechanism is not based on DNA mutation
or plasmid uptake. Instead, within an isogenic popula-
tion, without significant genotypic variation, there exists
selectable phenotypic variation based on stochastic differ-
ences in gene expression patterns. That is, heritable epige-
netic variation creates phenotypic diversity for natural
selection to act upon.
Results
Resistance rates
To re-create satellite colony forming conditions we placed
isogenic XL1-Blue E. coli, from a single colony, on agar
plates with several different low concentrations of amp.
Under our laboratory conditions the MIC (minimal
inhibitory concentration, giving no detectable growth in
liquid culture following an overnight incubation) was 2.5
μg/ml amp. We observed, however, that there was signifi-
cant cell death even at sub-MIC antibiotic concentrations.
For example, only 21% (+/-3%) of cells survived and
formed colonies on plates with 1 μg/ml amp.
This simple experiment demonstrates the existence of
selectable phenotypic variation in an isogenic population.
A significant fraction of cells survived, while most died,
similar to what is seen in the formation of satellite colo-
nies. The key question addressed in this study is why,
within a population of E. coli, will some individuals sur-
vive to form colonies while genetically identical neighbors
die?
It is important to note that percentage of cells surviving 1
μg/ml amp, at about 20%, is too high to be accounted for
by the occurrence of random spontaneous mutations. Fre-
quencies of stable mutation to even low levels of antibiot-
ics are far lower than this. For example, the rate of
selection of stable mutant low-level quinolone resistant
mutants in P. aeruginosa ranges from 1.2 × 10-6 to 4 × 10-
10, depending on the concentration of quinolone used [1].
While it is true that the frequency of mutation to antibi-
otic resistance is dependent on many variables, including
the number of target genes, and the numbers of positions
within those genes that can be mutated to confer resist-
ance, nevertheless the observed high rate of 20% argues
very strongly against an explanation based on stable DNA
mutations.
As expected, the percent survivors dropped dramatically as
the amp levels increased, with only approximately 1/105
cells surviving on the MIC concentration of 2.5 μg/ml
amp (Fig. 1). Survival rates were routinely determined by
performing parallel serial dilution platings on LB agar
with and without antibiotic.
We next asked if the survival rate could be ramped higher
by successive exposures to increasing concentrations of
amp. We found that this was indeed the case. For example,
cells surviving an initial exposure to 1 μg/ml amp were
then found to show over 50% survival on a second plating
on 1 μg/ml amp, compared to the original 20%, and cells
surviving 2.5 μg/ml amp gave survival rates of ~3% when
re-plated on 2.5 μg/ml, an improvement of over 1000 fold
compared to the 1/105 for cells not previously exposed to
amp (Fig. 1). Through such successive exposures to
increasing antibiotic concentrations it was possible to
evolve E. coli that survived on amp concentrations as high
as 10 μg/ml, yet showed very high reversion rates, indicat-
ing the absence of stable mutations conferring resistance.
Reversion rates
The high frequency of survival on low antibiotic concen-
trations suggested an epigenetics based resistance. Per-
haps some cells within the population were by chance
over expressing one or more genes that conferred low level
amp resistance. Epigenetic inheritance of this amp resist-
ance gene expression pattern would allow such a cell to
divide and form a colony, while neighboring cells without
this advantage would die.
To test this model we examined reversion rates. Amp
resistance due to changes in DNA sequence would be
extremely stable. Reversion to antibiotic sensitivity would
generally require back mutation of the precise base origi-BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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nally altered, a very infrequent event, estimated to be on
the order of 10-9 or less [2]. Epigenetic inheritance, on the
other hand, is based on more unstable processes, such as
maintenance of certain chromatin configurations and/or
DNA methylation states, and would give much higher
reversion rates.
We observed that the high frequency low level amp resist-
ance was indeed extremely unstable, showing very high
reversion rates to antibiotic sensitivity.
For example, over 95% of cells taken from a single colony
growing on a 2.5 μg/ml amp plate were unable to grow
when immediately transferred to a new plate with the
same 2.5 μg/ml amp concentration (Fig. 1). This immedi-
ate reversion rate of over 95% to amp sensitivity argues
strongly in favor of an epigenetic inheritance based mech-
anism, and against the involvement of DNA mutation.
These results are quite striking. When the cells of a colony
on a plate with 2.5 μg/ml amp were quickly resuspended
in LB broth and immediately re-plated in parallel on
plates with amp (2.5 μg/ml amp again), and without amp
to determine viable cell count, it was observed that over
95% of the cells placed on the amp plate failed to form a
colony. That is, over 95% of the cells reverted to antibiotic
sensitivity over the brief time span of the experiment. It is
clear from these results that this antibiotic resistant state is
extremely unstable.
It is also interesting to note that this instability disap-
peared as the time under selection, and antibiotic concen-
trations were increased. The cells surviving 30 μg/ml amp
showed variable but generally low reversion rates, suggest-
ing that most of these cells had now acquired stable DNA
mutations conferring amp resistance.
Selection Scheme
A "whole plate" selection scheme was primarily used (see
Methods). At each step of antibiotic selection we pooled a
few hundred colonies from a single plate, by adding five
ml of LB broth to the surface of the plate, scraping the cells
into the LB broth, and resuspending the cells by pipeting.
The cells were then immediately re-plated, in serial dilu-
tions, in the absence of antibiotic to determine viable cell
count, and on plates with different antibiotic concentra-
tions, to create survival curves, determine reversion rates,
and to select for increased antibiotic resistance.
Variable Gene Expression
To further investigate the basis of the antibiotic resistance
we examined gene expression patterns in multiple E. coli
populations surviving selection with 0, 1, 2.5, 5, 10 or 30
μg/ml amp, using a total of 35 Affymetrix E. coli version
2.0 microarrays (see Methods). Altered gene expression
patterns in resistant cells might reveal epigenetic based
survival mechanisms.
Biological replicates were used for the microarray analysis,
with each microarray representing an independently gen-
erated biological sample. The data was first examined with
GeneSpring software, performing an ANOVA analysis,
producing a list of differentially expressed genes. A heat
map provides a visual display of the results (Fig. 2). There
is some scatter in the data, perhaps reflecting the inherent
variability in the selection response and the possible exist-
ence of multiple resistance mechanisms.
Of particular interest, the list of genes with differential
expression included an endogenous E. coli gene with
known β-lactamase activity. This gene, AmpC, is present
in most laboratory strains of E. coli. A close relative of E.
coli, E. cloacae, carries an AmpR gene important in the
induction and repression of AmpC. It has been shown
that the AmpR gene was deleted from the E. coli genome
following the divergence of E. coli and E. cloacae from their
common ancestor [3]. This results in very low-level consti-
E. coli ampicillin survival curves Figure 1
E. coli ampicillin survival curves. All E. coli are isogenic, 
recently derived from a single colony. Triangles show survival 
rates for cells previously grown in the absence of ampicillin. 
Resistance rates were ramped higher by prior exposure to 
ampicillin. Cells surviving selection of 1 μg/ml ampicillin (cir-
cles) showed improved survival on both 1 μg/ml and 2.5 μg/
ml ampicillin. Cells surviving 2.5 μg/ml ampicillin (squares), 
showed even more dramatic improvement, with an approxi-
mately three log increase in survival on 2.5 μg/ml ampicillin. 
Nevertheless, reversion rates were extremely high, with for 
example over 95% of cells from 2.5 μg/ml ampicillin not sur-
viving dispersion and immediate re-plating on another LB 
agar plate with the same antibiotic concentration, 2.5 μg/ml 
ampicillin. Survival rates for previously unexposed E. coli at 
ampicillin concentrations of 5 μg/ml and higher were 
extremely low, below 1/106.BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
Page 4 of 12
(page number not for citation purposes)
tutive expression of AmpC in E. coli, allowing the use of
amp selection in cloning experiments, for example. Amp
resistance in E. coli has previously been associated with
stable DNA mutations resulting in novel AmpC promot-
ers, weakened attenuators or AmpC gene duplications [4-
8]. Of interest, however, we observed elevated expression
of AmpC not only in the stable amp resistant populations
(resistant to 30 μg/ml amp), but also in many of the
unstable amp resistant populations (resistant to 1, 2.5, 5
and 10 μg/ml amp) (Fig. 3).
These results suggest that AmpC can contribute to amp
resistance through three distinct mechanisms. In E. cloacae
the presence of amp can induce elevated AmpC expres-
sion through the action of the AmpR gene. That is, the
combination of the AmpR and AmpC genes provide a sur-
vival mechanism that is induced in the presence of amp.
In E. coli, without the AmpR gene, DNA mutations can
result in elevated AmpC expression and stable amp resist-
ance, as shown previously. In addition, in this report, we
show that unstable resistance to low levels of amp in E.
coli can be mediated through epigenetic events, likely sto-
chastic in nature, yet semi-stable, that result in elevated
AmpC expression.
To test for functionality in conferring amp resistance we
picked a total of eight genes with elevated expression fol-
lowing amp selection, after examining the microarray
data, and subcloned their coding sequences into an
expression vector plasmid, which was then introduced
into E. coli. The over-expression of the endogenous E. coli
AmpC gene did indeed confer dramatically increased amp
resistance, as expected, allowing all cells to survive on up
to 30 μg/ml amp, but not 100 μg/ml. None of the other
genes tested (see Methods) gave significant survival bene-
fits. These results argue that the observed increase in
expression of the endogenous AmpC gene was responsi-
ble, at least in some cases, for the observed amp resistance.
It is not surprising that many of the genes with elevated
expression following amp selection were unable to confer
amp resistance. It has been previously shown that very
low, subinhibitory concentrations of antibiotics can cause
significant changes in bacterial gene expression patterns.
For example, it was shown in Salmonella typhimurium,
using a promoter-Lux reporter library, that many promot-
ers responded to low levels of erythromycin and
rifampicin, below the MIC [9].
In an attempt to remove some of the induced genes unre-
lated to antibiotic resistance from the list of differentially
Expression levels of endogenous β-lactamase gene in E. coli  surviving selection at different ampicillin concentrations Figure 3
Expression levels of endogenous β-lactamase gene in 
E. coli surviving selection at different ampicillin con-
centrations. Transcript abundances were determined using 
a total of 29 Affymetrix E. coli 2.0 oligonucleotide microar-
rays. Expression levels are in arbitrary Affymetrix expression 
units. Survivors at higher ampicillin concentrations show sig-
nificantly increased β-lactamase expression. Heat map showing changing gene expression patterns in  ampicillin resistant E. coli Figure 2
Heat map showing changing gene expression pat-
terns in ampicillin resistant E. coli. Each column repre-
sents one population grown in the absence of amp (C), or in 
the concentration of amp shown at the bottom. Each row 
shows the expression level across populations for one gene, 
with blue for low, red for high and yellow for intermediate 
expression. The endogenous β-lactamase gene, AmpC, shows 
elevated expression in most, but not all, ampicillin resistant 
populations.BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
Page 5 of 12
(page number not for citation purposes)
expressed genes we re-analyzed the microarray data, only
this time including the data from E. coli exposed to very
low levels of amp (1 μg/ml) in the control group. This
more specifically looked for genes that showed increasing
change in expression concordant with survival in the pres-
ence of increasing levels of amp. A pairwise t-test was per-
formed using GeneSifter software. The top five genes on
the resulting list, ranked by fold change, were as follows.
(1.) Glutamate decarboxylase (GadA), up 7.2 fold, p =
0.021. (2.) The second gene on the list encodes a separate
glutamate decarboxylase (GadB) up 6.1 fold, p = 0.014. It
is interesting that the top two genes on the list are located
at very different genomic positions, yet encode isozymes
very similar in sequence and function. (3.) The third gene,
GadC, encodes an APC transporter that mediates export of
gamma-aminobutyrate in exchange for glutamic acid. The
GadC gene is located on the same operon as GadB, pro-
viding a measure of cross-validation. (4.) The fourth gene,
AmpC, was up-regulated 4.4 fold, with a p value of 0.0034
(the lowest p value). (5.) The fifth gene, hdeB, was up 4.0
fold, p = 0.011, and encodes an acid stress chaperone.
It is quite interesting that the two genes showing the great-
est upregulation in more amp resistant cells encode iso-
zymes that both decarboxylate glutamate (Fig. 4). There
are reasons to suspect that this overexpression of gluta-
mate decarboxylase could be functionally related to amp
resistance. Glutamate decarboxylase removes a carboxyl
group from glutamic acid (which is neuro-excitatory in
mammals), producing gamma-aminobutyric acid (GABA,
neuro-inhibitory in mammals). There is a surprising con-
nection between penicillin and glutamate-GABA in mam-
mals. Penicillin is a GABAA receptor blocker and can be
used to induce convulsions in animal models of epilepsy
[10-12]. This ability of penicillin to interact with a GABA
receptor suggests a steric similarity between penicillin and
glutamate-GABA. Of interest, both penicillin, (as well as
ampicilliin), and glutamate do carry a carboxyl group in a
comparable chemical setting (Fig. 5). Indeed the struc-
tural similarity between a region of ampicillin (including
the carboxyl group) and the backbone of a peptide chain
have been used to explain the mechanism of action of β-
lactam antibiotics. This suggests that glutamate decarbox-
ylase might be capable of removing the carboxyl group
from ampicillin, thereby inactivating it.
Previous work also suggests another possible role for
glutamate decarboxylase in antibiotic resistance. The
decarboxylation reaction consumes a proton, contribut-
ing to membrane potential difference, which in turn is
used by the AcrAB multi-drug efflux pump [13]. The over-
expression of the GadA and GadB genes may therefore
provide increased power to the AcrAB pump.
To test GadA for possible function in providing amp
resistance we made a GadA expression plasmid and intro-
duced it into the XL1-Blue E. coli. We observed that the
XL1-Blue  E. coli with the GadA expression construct
showed somewhat improved survival rates, five fold
higher colony formation on 1.75 μg/ml amp compared to
cells without (P = 0.014). These results suggest that over
expression of GadA, and likely the isozyme GadB, can
contribute to survival under amp selection conditions.
Therefore the increased expression of GadA and GadB
could be the result of stochastic variation in expression
levels of these genes coupled with amp selection for cells
with higher expression. It is also interesting to note the
possibility that just as penicillin can perturb glutamate
signaling in the mammalian brain, perhaps through its
structural similarity to glutamate, penicillin (or ampicil-
lin) can induce GadA and GadB expression in E. coli.
Elevated expression of GadA and GadB genes in ampicillin  resistant populations Figure 4
Elevated expression of GadA and GadB genes in amp-
icillin resistant populations. Both genes encoding the two 
glutamate decarboxylase isozymes show significantly elevated 
expression in ampicillin resistant E. coli populations.BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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Nalidixic Acid and Tetracycline
To study the epigenetic based evolution of antibiotic
resistance further, and in particular to determine if this
was a general phenomenon or restricted to ampicillin, we
performed similar selection experiments using two addi-
tional antibiotics, nalidixic acid and tetracycline. These
three antibiotics exhibit distinct modes of action, with
ampicillin disrupting cell wall biosynthesis, nalidixic acid
inhibiting DNA synthesis and tetracycline blocking pro-
tein synthesis.
Interestingly, the results for the nalidixic acid and tetracy-
cline selection experiments closely mirrored those
observed using ampicillin, showing the generality of epi-
genetic inheritance mediated evolution of antibiotic
resistance. For example, again starting with isogenic XL1-
Blue E. coli, we established a nalidixic acid survival curve,
finding survival rates that varied from about 40% on 20
μg/ml nalidixic acid to about 1 in 100,000 on 80 μg/ml
nalidixic acid (Fig. 6). For reference, the nalidixic acid
MIC for XL1-Blue E. coli was 40 μg/ml. As for ampicillin,
the survival rates under low concentration antibiotic con-
centration selection were too high to be accounted for by
spontaneous mutation. This was confirmed by testing
reversion rates, which with rare exception were again very
high, indicating that the resistance was not the result of a
stable change in DNA sequence (Fig. 6).
The XL1-Blue E. coli carry a stable mutation in the gyrase
gene (gyrA96), conferring significantly greater nal resist-
ance than found in wild type E. coli, which typically would
not survive even 10 μg/ml nalidixic acid. In this series of
experiments, therefore, we started with E. coli showing
moderate levels of nal resistance, and examined the evo-
lution of increased resistance to still higher antibiotic con-
centrations.
Once again the resistance rates could be elevated by suc-
cessive antibiotic selection. For example, upon initial
exposure to 40 μg/ml nalidixic acid approximately 1/
1,000 cells survived to form a colony. When cells from a
40 μg/ml nalidixic acid plate, however, were re-plated on
another plate with 40 μg/ml nalidixic acid, then about
20% survived to form colonies, showing a dramatic
improvement in survival rate. This also illustrates the high
reversion rate, as 80% of cells do not survive a re-plating
on 40 μg/ml nalidixic acid.
The ability to ramp antibiotic resistance higher by succes-
sive exposures was also illustrated by the survival rates on
higher concentrations of nalidixic acid. For example,
upon initial exposure to 80 μg/ml nalidixic acid only
about one cell in 100,000 survived. But if cells surviving
exposure to 40 μg/ml were subsequently selected at 80 μg/
ml then almost 1 cell in 100 survived, approaching a
1,000 fold improvement (Fig. 6).
E. coli nalidixic acid survival curves Figure 6
E. coli nalidixic acid survival curves. As observed for 
ampicillin, the survival rates at low nalidixic acid concentra-
tions are too high to be accounted for by spontaneous muta-
tion. Cells surviving prior antibiotic exposure show 
dramatically improved resistance rates, yet reversion to anti-
biotic sensitivity is very common, with over 95% of cells from 
40 μg/ml nalidixic acid not surviving re-exposure to the same 
antibiotic concentration. No previous nalidixic acid expo-
sure, triangles. From 40 μg/ml nalidixic acid, circles.
Structures of glutamate and ampicillin Figure 5
Structures of glutamate and ampicillin. Similarities 
between the lactam ring and the peptide backbone have been 
proposed to be responsible for the antibiotic function of 
ampicillin.BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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For the tetracycline selection experiments we used a differ-
ent strain of E. coli [XL1-Blue (MRF')], as the standard
XL1-Blue cells carry genes conferring strong tet resistance.
The XL1-Blue (MRF') cells (Stratagene) are closely related
to XL1-Blue cells (see Methods), only with kanamycin
resistance instead of tetracycline resistance. The results of
tetracycline selection using single colony derived isogenic
XL1-Blue (MRF') cells showed a similar pattern to that
observed for both ampicillin and nalidixic acid. The tetra-
cycline MIC for XL1-Blue (MRF') E. coli was 1.0 μg/ml.
Once again, resistance and reversion rates were far too
high to be accounted for by stable DNA mutations, and
once again it was possible to ramp up resistance rates by
successive exposures to increasing concentrations of anti-
biotic (Fig. 7).
Molecular Mechanisms
The observed semi-stable epigenetic inheritance could be
mediated by DNA methylation [14], chromatin modifica-
tions, superhelical domain configuration [15], or perhaps
other mechanisms. DNA methylation in particular pro-
vides a plausible mechanism for the observed metastable
antibiotic resistance. The E. coli deoxyadenosine methyl-
transferase (DAM), for example, methylates the adenine
of the GATC sequence. This sequence occurs approxi-
mately 18,000 times in the E. coli genome, and the two
copies of this palindromic sequence opposite each other
on DNA are generally both methylated. Following DNA
replication, however, the DNA is transiently hemimethyl-
ated, and the new strand is then methylated by DAM.
For a few sites in the E. coli genome, however, the methyl-
ation status of the DAM target, GATC, is variable and can
impact gene expression. Of particular interest, the flu gene
is a metastable locus encoding the Ag43 protein, which is
an outer membrane protein promoting cell-cell aggrega-
tion important in biofilm production. Phase variation, in
both directions (Ag43+ to Ag43- and vice versa), is metast-
able and occurs with a frequency of approximately 10-3
[16]. DAM and OxyR repressor compete for binding to
sequences in the flu promoter, with OxyR binding result-
ing in repression and blocking of methylation, while
DAM methylation is required for full gene activation [17].
A previous microarray analysis of gene expression patterns
associated with biofilms showed a strong upregulation of
the flu gene [18]. Indeed, it was shown that E. coli with a
mutation of this gene were unable to form biofilms [18].
Because of the metastable binary expression of this gene,
and its strong association with biofilms, and the known
multidrug antibiotic resistance of biofilm E. coli compared
to E. coli undergoing planktonic growth, we were particu-
larly interested in the expression levels of the flu gene in
the antibiotic resistant E. coli in this study. Interestingly,
we observed no change in flu gene expression in the amp
resistant cells, arguing against the involvement of a bio-
film type genetic program in the antibiotic resistance.
Although the elevated expression of the flu gene, and con-
sequent biofilm production, did not appear associated
with the antibiotic resistance described in this report, nev-
ertheless the DNA methylation mediated metastable
expression of the flu gene provided a useful model for pos-
sible regulation of other genes that might indeed be
responsible for the observed selectable antibiotic resist-
ance.
Only a small number of genes were shown to be altered in
expression in Dam methylation mutant E. coli [19]. The
18 genes with over 2 fold change in DAM mutant cells
included representatives of the Csg and Mar operons,
which were both down regulated in the absence of DAM
methylation.
To test the possible function of DNA methylation in the
observed evolution of antibiotic resistance we examined
the ER2925 strain of E. coli K12, which is deficient for
both DAM and DCM dependent DNA methylation. We
generated both DAM positive and DCM positive variants
of the ER2925 cells by making DAM and DCM expression
plasmids, allowing a direct comparison of cells with and
without these specific DNA methylases. We observed that
DCM had no apparent effect on antibiotic survival, while
DAM methylase did improve the survival rate by a factor
of five on nalidixic acid (40 μg/ml).
E. coli tetracycline survival curves Figure 7
E. coli tetracycline survival curves. Survival ratios for E. 
coli not previously exposed to tetracycline (triangles), and for 
E. coli previously surviving exposure to 2 μg/ml tetracycline 
(circles).BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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Discussion
In this report we present data strongly supporting the con-
clusion that evolution can occur without mutation. A
model to explain the observed evolution of antibiotic
resistance is illustrated in Fig. 8. Within an isogenic popu-
lation of E. coli there is random variation in the expression
levels of genes, creating phenotypic variation. This epige-
netic variation shows an element of heritability. Some
cells with elevated expression of genes conferring antibi-
otic resistance survive antibiotic selection, as do sufficient
progeny to allow colony formation.
The cells with increased expression of resistance genes in
turn show variation in expression levels, but now under
selection and therefore with sustained elevated levels,
allowing selection of still higher degrees of resistance.
Serial exposure to rising concentrations of antibiotic
results in cells with higher resistance than possible with a
single round of selection (Fig. 8).
We show that there are several categories of resistance
genes. The endogenous E. coli AmpC gene represents a
cryptic gene, normally not significantly expressed, but
when activated capable of conferring potent antibiotic
resistance. The glutamate decarboxylase genes normally
provide an acid resistance function, allowing E. coli to
transit the acidic conditions of the stomach. Elevated
glutamate decarboxylase gene expression can also some-
what improve survival in the presence of ampicillin, likely
incidental to its normal function. In addition there are
genes like DAM that can improve survival by regulating
the expression of other genes.
The evolution of resistance within the population is
driven by a powerful antibiotic selective pressure coupled
with phenotypic diversity created by heritable epigenetic
variation. The extreme instability of the observed low
level antibiotic resistance argues strongly that it does not
involve DNA mutation events, or induced gene expression
survival mechanisms.
Bacteria, antibiotics and microarrays
It is important to note that several interesting previous
studies examined the global effects of antibiotics on bac-
teria, often using microarrays [20-31]. Much of this work
investigated mechanisms of antibiotic action and resist-
ance, with the goal of discovering novel antimicrobial
drugs. In some cases the survival benefits of antibiotic
induced gene expression patterns are discussed [31,32]. A
simple example would be the presence of tetracycline
inducing the expression of a tetracycline resistance
operon. Similarly, antibiotics causing DNA damage can
induce an SOS DNA repair response [22,23,25].
These studies do not, however, address the issue of how
epigenetic inheritance of stochastic variations in gene
expression levels can provide survival advantage under
antibiotic selection, as examined in this report. An exam-
ple is our observation that epigenetic inheritance of ele-
vated expression of AmpC, a gene not normally expressed
in E. coli, significantly improves survival in the presence of
ampicillin.
Persisters
The phenomena described in this report are also distinct
from the previously described bacterial persisters. For
example, when E. coli K12 are exposed to a high concen-
tration of ampicillin, 100 μg/ml, a small fraction of the
cells, 10-5 to 10-6, can survive, and are referred to as per-
sisters [33]. These persisters, however, do not grow in the
presence of the antibiotic, but only after its removal, and
the progeny of persisters do not show an increased resist-
ance to antibiotic. All three aspects of persisters, very low
frequency, failure to grow in the presence of the antibiotic,
and no increased resistance of progeny, distinguish per-
sisters from the low level antibiotic resistant bacteria
described in this report.
Transcriptional state memory
We suggest that the observations described in this report
are the result of two competing processes. On the one
hand, there is noise, or stochastic variation in gene expres-
Model of evolution of antibiotic resistance through epige- netic inheritance Figure 8
Model of evolution of antibiotic resistance through 
epigenetic inheritance. Within an isogenic population of 
E. coli there is random variation in expression levels of genes. 
Antibiotic exposure (horizontal arrows) selects cells with 
gene expression patterns that allow survival. For example, 
elevated expression of the GadA and β-lactamase genes pro-
mote ampicillin survival. A combination of continued selec-
tion, epigenetic inheritance and stochastic variation can 
evolve populations with gene expression patterns providing 
increasing antibiotic resistance.BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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sion patterns, even within an isogenic population. This
has been well documented in both bacteria and eukaryo-
tes [34-37] and is thought to be the result in part of the
probabilistic nature of mass action, with for example
small numbers of transcription factors and promoter ele-
ments interacting in a single cell. On the other hand, once
a gene expression pattern is established there are epige-
netic memory mechanisms capable of preserving the gene
expression state for multiple generations. Transcriptional
memory can be mediated by DNA methylation patterns,
as discussed previously, or by inherited chromatin modi-
fications, or it can be a property of the genetic regulatory
network. It is interesting to note, for example, that early
studies of the lac operon showed that expression was gen-
erally quantal in nature, being on or off, depending on
inducer concentration, but that at intermediate concentra-
tions the expression state depended on the history of the
cell and was stable for many generations [38].
Our results are consistent with the presence of cooperative
effects in the amp resistant colonies. It is likely that some
cells within the colony degrade amp through elevated
AmpC expression, thereby promoting survival of all cells
within the colony, and explaining why many cells within
the colony appear to be antibiotic sensitive when assayed
singly on a fresh antibiotic plate.
Medical significance
The epigenetic inheritance based evolution described in
this report could be of medical importance, by allowing a
subpopulation of bacteria within a person to survive low
doses of antibiotic. The low dose exposure could be from
inappropriate antibiotic administration, from a food
source, or through a protected microenvironment within
the body. The cells with low-level resistance could then
produce sufficient numbers for a sufficient period of time
to accumulate more stable DNA mutations that confer a
higher level antibiotic resistance.
Conclusion
In summary we describe an example of an isogenic popu-
lation showing selectable phenotypic variation, mediated
by epigenetic inheritance. It is interesting to note that
many examples of epigenetic inheritance between genera-
tions have been reported in metazoans as well, including
paramutation in plants [39], the FAB-7 DNA element in
Drosophila [40], and RNA-mediated epigenetic inherit-
ance in the mouse [41]. It is reasonable to suppose that
such mechanisms generating heritable phenotypic varia-
tion could provide the substrate for the action of natural
selection.
Methods
E. coli strains
For amp and Nal experiments strain XL1-Blue E. coli
(Stratagene) (recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 lac [F' proAB lacIqZΔM15 Tn10(Tetr) were streaked
on an LB agar plate and a single resulting colony was used
for inoculation of a 50 ml LB liquid culture, which was
grown to mid-log phase and then used to make one set of
frozen aliquots, which were used for all of the amp and
nal resistance studies. The frozen aliquots were thawed,
grown in LB culture to mid-log phase, and subjected to
amp or nal antibiotic selection on agar plates. For the tet-
racycline resistance experiments we use XL1-Blue (MRF')
cells (Stratagene) with the following genotype
Δ(mcrA)183Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44
thi-1 recA1 gyrA96 relA1 lac[F' proAB lacIq  ZΔM15
Tn5(Kanr]. For testing the role of DNA methylation we
used dam-, dcm-ER2925 E. coli from New England
Biolabs (ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2
galT22 mcrA dcm-6 hisG4 rfbD1 R(zgb210::Tn10)TetS
endA1 rpsL136 dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1
hsdR2).
MIC determination
A 2 ml LB culture was inoculated from frozen stocks for
each of the cell types and grown to log phase. Approxi-
mately 105 cells were inoculated into each tube of a two
fold serial dilution of each antibiotic in LB. The cultures
were grown two days at 37°C in a shaking incubator. The
MIC was determined to be the lowest concentration of
antibiotic resulting in no turbidity, or apparent growth of
the culture.
Selection protocols
We primarily used a "whole plate" selection scheme. Log
phase XL1-Blue cells were plated on LB only, and on LB
plates with varying antibiotic concentrations. The cells
from a few hundred colonies on a low antibiotic concen-
tration plate were then pooled, and again plated on LB
only, for titering cell concentration, as well as on plates
with varying antibiotic concentrations, to determine sur-
vival rates, reversion rates, and to increase antibiotic
resistance. This process was repeated with increasing anti-
biotic concentrations. For example, cells not previously
exposed to antibiotic were first grown on 1 μg/ml amp
agar plates, a few hundred colonies of surviving cells were
pooled, resuspended in LB broth and plated on agar with-
out antibiotic to determine viable cell concentration, on
another plate with 1 μg/ml amp to determine reversion
rate, and on plates with higher concentrations of amp to
determine the survival curve and to select for higher amp
resistance levels.
We found that this selection procedure eventually
exposed sufficient numbers of E. coli for enough time toBMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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allow the accumulation of stable antibiotic resistance
mutations, typically at 30 μg/ml amp.
Gene expression profiles of cells surviving 0 (three micro-
arrays), 1.0 μg/ml amp (four microarrays), 2.5 μg/ml amp
(five microarrays), 5.0 μg/ml amp (four microarrays),
10.0 μg/ml amp (two microarrays), 20.0 μg/ml amp (one
microarray) and 30.0 μg/ml amp (four microarrays) were
determined.
The variable sizes of the resistant colonies suggested the
presence of different growth rates, and different levels of
antibiotic resistance among individual colonies. To
reduce the numbers of E. coli exposed to selection, to
reduce the incidence of stable mutations, and to begin to
define the individual differences among colonies, we also
tested a single colony selection scheme, using single colo-
nies from selection plates instead of pooling hundreds of
colonies. Because of the smaller numbers of cells
involved, however, we were unable to select populations
of E. coli with greater than 5 μg/ml amp resistance. The
populations generated were also subjected to microarray
analysis, using three arrays each to examine expression
profiles of cells surviving 1.0 and 2.5 μg/ml amp.
A third selection scheme used concentrated cell streaks
instead of single colonies, emphasizing the community
effects on survival. Expression profiles were determined
for cells surviving 1.0 μg/ml amp (two microarrays), 2.5
μg/ml amp (two microarrays), 5.0 μg/ml amp (two micro-
arrays) and 10.0 μg/ml amp (three microarrays).
Assaying genes for antibiotic resistance function
The amp resistance gene in the pl451 plasmid was
removed by restriction digestion with BsaI and XmnI,
blunting with Klenow, and ligation. A ScaI restriction site
was introduced immediately downstream of the promoter
of the deleted amp gene using the QuickChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) and
the primer pair GGGCGACACGGAAATGTTGAATACTAG-
TACTCTTCCTTTTTC, GAAAAAGGAAGAGTACTAGTAT-
TCAACATTTCCGTGTCGCCC.
The coding sequences of the genes to be tested were
amplified by high fidelity PCR and used for in vivo sub-
cloning into the linearized Sca1 site of pl451 using the Xi-
Clone High Speed Cloning Kit (Genlantis, San Diego,
CA). The resulting constructs showed no signs of instabil-
ity. Genes were assayed for amp resistance function in
XL1-Blue cells. Primers used for amplification were as fol-
lows:
YedH (multi drug resistance pump)
ATGCTTCAATAATATTGAAAAAGGAAGAGTGTGCA-
GAAGTATATCAGT and AAGGGCGACACGGAAATGTT-
GAATACTAGTTTAGCGGGATGCTCGTTG,
bdb 945215
ATGCTTCAATAATATTGAAAAAGGAAGAGTATGATCT-
GGAAACGCCATTTA, AATAAGGGCGACACGGAAAT-
GTTGAATACTAGTTCATCCCAAAACTGCCG,
YedX
TGCTTCAATAATATTGAAAAAGGAAGAGTATGT-
TAAAGCGTTATTTAGTA, AAGGGCGACACGGAAATGTT-
GAATACTAGTTTAACTGCCACGATAGGT,
Z0726
TGCTTCAATAATATTGAAAAAGGAAGAGTATGGCAT-
TCAGTAATCCC,
AATAAGGGCGACACGGAAATGTTGAATACTAGTTCATT-
GTGCCTCCTGCA, 2-isopropylmalate synthase (LeuA)
TAAATGCTTCAATAATATTGAAAAAGGAAGAGTAT-
GAGCCAGCAAGTC,
AAGGGCGACACGGAAATGTTGAATACTAGTTCACACG-
GTTTCCTTGTTGTTT, Sulfate adenyltransferase subunit1
TAAATGCTTCAATAATATTGAAAAAGGAAGAGTAT-
GAACACCGCACTTGCACA,
AATAAGGGCGACACGGAAATGTTGAATACTAGTTTATT-
TATCCCCCAGCAAATC,
Sulfate adenyltransferase subunit2
TAAATGCTTCAATAATATTGAAAAAGGAAGAGTAT-
GGATCAAATACGAC,
AATAAGGGCGACACGGAAATGTTGAATACTAGTT-
TAAAAATACCCCTGACGTT
β-lactamase (AmpC) TGCTTCAATAATATTGAAAAAG-
GAAGAGTATGTTCAAAACGACGCTCTG,
AATAAGGGCGACACGGAAATGTTGAATACTAGTTTACT-
GTAGAGCGTTAAGA.
DAM
5-GCTTCAATAATATTGAAAAAGGAAGAGTATGAA-
GAAAAATCGCGCTTT-3
5-AAGGGCGACACGGAAATGTTGAATACTAGTT-
TATTTTTTCGCGGGTGAAA-3BMC Evolutionary Biology 2008, 8:52 http://www.biomedcentral.com/1471-2148/8/52
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DCM
5-TGCTTCAATAATATTGAAAAAGGAAGAGTATGCAG-
GAAAATATATCAGTA-3
5-AGGGCGACACGGAAATGTTGAATACTAGTTTATCGT-
GAACGTCGGCCATG-3
GadA
5-TGCTTCAATAATATTGAAAAAGGAAGAGTATGGAC-
CAGAAGCTGTTAACG-3
5-AGGGCGACACGGAAATGTTGAATACTAGTTCAGGT-
GTGTTTAAAGCTGTT-3
Microarray analysis
We harvested E. coli (XL1-Blue) from agar plates with
1000–2000 colonies by adding 5 ml of LB broth and
scraping to resuspend. Approximately 109 cells were pel-
leted and RNA was isolated using the RNeasy mini prep
kit (Qiagen, Valencia, CA). cDNA was synthesized, frag-
mented, labeled, and hybridized to microarrays as per the
Affymetrix prokaryotic sample and array processing pro-
tocol (Affymetrix, Inc., Santa Clara, CA).
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